Resverlogix Corp. Stock OTC Markets
Stocks
RVXCF
CA76128M1086
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0692 USD | +4.56% |
|
-0.86% | -6.74% |
| Market Cap | 23.37M 16.72M 14.41M 13.26M 12.44M 1.58B 23.6M 157M 61.24M 774M 62.74M 61.41M 2.68B | P/E Ratio 2024 |
-1.38x | P/E Ratio 2025 | -2.68x |
|---|---|---|---|---|---|
| Enterprise Value | 109M 78.09M 67.31M 61.94M 58.11M 7.38B 110M 732M 286M 3.61B 293M 287M 12.51B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
60.39% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Resverlogix Corp.
| 1 day | +4.56% | ||
| 1 week | -0.86% | ||
| Current month | -5.46% | ||
| 1 month | -3.08% | ||
| 3 months | -19.35% | ||
| 6 months | -8.95% | ||
| Current year | -6.74% |
| 1 week | 0.07 |  | 0.07 |
| 1 month | 0.05 | | 0.07 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.02 | | 0.21 |
| 3 years | 0.02 | | 0.21 |
| 5 years | 0.02 | | 0.73 |
| 10 years | 0.02 | | 4.14 |
| Manager | Title | Age | Since |
|---|---|---|---|
Donald McCaffrey
CEO | Chief Executive Officer | - | 25/04/2003 |
Anthony Cann
DFI | Director of Finance/CFO | 78 | 29/10/2009 |
| Chief Tech/Sci/R&D Officer | - | 15/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Donald McCaffrey
CHM | Chairman | - | 04/04/2016 |
Kelly McNeill
BRD | Director/Board Member | 56 | 15/10/2009 |
Kenneth Zuerblis
BRD | Director/Board Member | 66 | 29/09/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.56% | -0.86% | - | - | 24.63M | |
| -2.86% | -0.26% | +51.45% | +110.98% | 56.42B | |
| -0.34% | +3.51% | +45.55% | +40.16% | 44.54B | |
| +0.29% | +6.20% | -14.80% | -19.65% | 22.9B | |
| -0.40% | +3.49% | -1.29% | +387.06% | 21.21B | |
| -2.39% | +0.87% | +13.96% | -36.35% | 16.4B | |
| -1.54% | -1.06% | +7.63% | -39.28% | 15.4B | |
| -0.24% | +2.44% | +27.43% | +177.49% | 13.35B | |
| -2.10% | +5.94% | +15.09% | - | 12.36B | |
| +0.32% | +2.81% | +96.37% | +213.49% | 11.15B | |
| Average | -0.46% | +1.51% | +26.82% | +104.24% | 23.75B | |
| Weighted average by Cap. | -1.24% | +1.93% | +30.60% | +96.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -7.64M -5.46M -4.71M -4.33M -4.06M -516M -7.71M -51.22M -20.01M -253M -20.5M -20.06M -875M | -7.77M -5.56M -4.79M -4.41M -4.13M -525M -7.84M -52.11M -20.35M -257M -20.85M -20.41M -890M |
| Net Debt | 81.87M 58.57M 50.48M 46.46M 43.58M 5.54B 82.69M 549M 215M 2.71B 220M 215M 9.38B | 85.79M 61.37M 52.9M 48.68M 45.67M 5.8B 86.65M 576M 225M 2.84B 230M 225M 9.83B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/06/26 | 0.0692 $ | +4.56% | 150 |
| 12/06/26 | 0.0662 $ | -5.19% | 160 |
- Stock Market
- Stocks
- RVX Stock
- RVXCF Stock
Select your edition
All financial news and data tailored to specific country editions
